Screening for prostate cancer: evidence and perspectives
Open Access
- 1 November 2001
- journal article
- research article
- Published by Wiley in BJU International
- Vol. 88 (8) , 811-817
- https://doi.org/10.1046/j.1464-4096.2001.02449.x
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Decrease in prostate cancer mortality following introduction of prostate specific antigen (PSA) screening in the Federal State of Tyrol, Austria, 1993–1999European Journal Of Cancer, 2001
- Cancer Statistics, 2001CA: A Cancer Journal for Clinicians, 2001
- Recommendations on cancer screening in the European UnionEuropean Journal Of Cancer, 2000
- Quebec randomized controlled trial on prostate cancer screening shows no evidence for mortality reductionThe Prostate, 1999
- Improvement in survival of patients with cancer of the kidney in EuropeEuropean Journal Of Cancer, 1998
- Comparison of pathologic characteristics of T1c and non-Tic cancers detected in a population-based screening study, the European randomized study of screening for prostate cancerWorld Journal of Urology, 1997
- Prostate-specific antigen doubling times in patients who have failed radical prostatectomy: Correlation with histologic characteristics of the primary cancerUrology, 1997
- Systematic 5 Region Prostate Biopsy is Superior to Sextant Method for Diagnosing Carcinoma of the ProstateJournal of Urology, 1997
- Progression in Untreated Carcinoma of the Prostate Metastatic to Regional Lymph Nodes (Stage T0 to 4,N1 to 3,M0,D1)Journal of Urology, 1995
- Serum concentrations of prostate specific antigen and its complex with α1-antichymotrypsin before diagnosis of prostate cancerThe Lancet, 1994